Synthetically-derived and previously inaccessible modifications of 20′-hydroxy-vinca derivative compounds such as vinblastine, vincristine or vindesine are disclosed that are a stunning 100-fold more active than the natural product (IC50's 50-75 pM vs 7 nM, HCT116), and are now accessible as a result of advances in the total synthesis of the natural product. Illustrative new ultra-potent vinblastines bind tubulin with much higher affinity and likely further disrupt the tubulin head-to-tail α/β dimer-dimer interaction by virtue of the strategic placement of an added conformationally well-defined, rigid and extended C20′-urea along the adjacent protein-protein interface. Added molecular complexity was used to markedly enhance target binding and functional biological activity, and represents a general approach to improving the properties of other natural products targeting a protein-protein interaction. A pharmaceutical composition containing an ultra-potent 20′-hydroxy-vinca derivative compound and a method of treating cancerous cells with such a compound are also disclosed.
本研究揭示了 20′-羟基
长春新碱衍
生物化合物(如
长春新碱、
长春新碱或
长春新碱)的合成衍
生物和以前无法获得的修饰物,其活性比
天然产物高出 100 倍(IC50 为 50-75 pM 对 7 nM,HCT116),由于
天然产物全合成技术的进步,现在可以获得这些修饰物。举例说明的新型超强
长春新碱能以更高的亲和力与微管蛋白结合,并可能进一步破坏微管蛋白头尾α/β二聚体之间的相互作用,这是因为在相邻的蛋白质-蛋白质界面上战略性地放置了一个构象明确、刚性和延伸的C20′-
脲。增加的分子复杂性可显著增强目标结合力和功能性
生物活性,是改善其他天然产品针对蛋白质-蛋白质相互作用特性的通用方法。此外,还公开了一种含有超强 20′-羟基长春花衍
生物化合物的药物组合物,以及用这种化合物治疗癌细胞的方法。